Administrative and Engagement Core

行政和参与核心

• 批准号: 10738440
• 负责人: Juliet Iwelunmor
• 金额: $ 19.84万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10738440
• 关键词: Acceleration; Address; Adoption; Attention; Award; Cancer Control; Cancer Vaccines; Caring; Cervical cancer vaccine; Cessation of life; Clinical Services; Collaborations; Communication; Communities; Community Outreach; Country; Creativeness; Development; Educational workshop; Ensure; Environment; Equity; Ethics; Evaluation; Fostering; Foundations; Goals; Guidelines; Health; Health system; Hepatitis B Vaccines; Human Papilloma Virus Vaccine; Human Resources; Incidence; Individual; Infrastructure; Intervention; Logistics; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Malignant neoplasm of liver; Medical Research; Methods; Modeling; Nigeria; Nigerian; North Carolina; Persons; Prevention; Process; Protocols documentation; Public Health; Research; Research Institute; Research Personnel; Resource-limited setting; Role; Societies; Surveys; Teleconferences; Testing; Training; Translational Research; Travel; United States National Institutes of Health; Universities; Vaccines; Visual impairment; World Health Organization; access disparities; community engagement; community involvement; community setting; cost; crowdsourcing; evidence base; health goals; implementation science; implementation strategy; improved; mortality; novel; operation; outreach; programs; response; success; symposium

Nigeria is at a crossroads in its cancer control response. On the one hand, the country remains an epicenter of a growing cancer crisis. On the other hand, there are existing guidelines (e.g., the National Cancer Control Plan2 by the Nigerian Ministry of Health, the Costing for Cervical Cancer Elimination in Nigeria by the World Health Organization,3 a Society-wide guideline for cervical cancer elimination,4 and a recent National Strategic Framework on vaccines for cancer control).5 These have accelerated the tempo and created new opportunities to achieve the country's vision for reducing the incidence and mortality of cancer in Nigeria. As a result, to support novel partnerships within and beyond traditional clinical services, including in community settings and non-health sector organizations, we propose the US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE) Administration and Engagement Core (AEC). Our overarching goal is to improve cancer control in Nigeria and exert a sustained impact on public health in partnership with key stakeholders. Our proposed U54 Center brings together a transdisciplinary research team to meaningfully collaborate with key stakeholders, including individuals, communities, and local and state ministries of health. The U54 program will foster a Nigerian implementation science (IS) program to optimize the implementation of vaccines for cancer control efforts in Nigeria. The AEC will be responsible for the overall administration, coordination, and management of the Center and communication with the NIH. It will foster collaboration between researchers and key stakeholders and provide critical infrastructure for equitable implementation of evidence-based vaccines (i.e. human papillomavirus (HPV) vaccines for cervical cancer and hepatitis B (HepB) vaccines for liver cancer) for cancer control. We will also set a national and global standard for cutting-edge participatory IS research approaches9 in a resource-constrained setting that accelerates the adoption, adaptation, and sustainability of effective cancer control interventions in Nigeria. Our specific aims are: 1) To coordinate project management of the center wide-activities using agile methods; 2) To serve as a community engagement hub for IS in Nigeria using crowdsourcing methods; and 3) To evaluate Center's milestones and overall progress. By providing an infrastructure that facilitates Center-wide communications, operations, community outreach and evaluation, the AEC will serve as a central focal point to reinforce the overall vision of reducing the incidence and mortality of cancer while advancing the role of IS for equitable cancer control in Nigeria.

尼日利亚正处于癌症控制对策的十字路口。一方面，该国仍然是 日益严重的癌症危机另一方面，现有的指导方针（例如，国家癌症控制 计划2由尼日利亚卫生部，成本为消除宫颈癌在尼日利亚由世界 卫生组织，3全社会消除宫颈癌指南，4和最近的国家战略 5这些措施加快了克里思，创造了新的机会 以实现该国降低尼日利亚癌症发病率和死亡率的愿景。因此，为了 支持传统临床服务内外的新型伙伴关系，包括在社区环境中， 非卫生部门组织，我们建议美国-尼日利亚癌症控制中心研究 实施科学和公平（C3-RISE）管理和参与核心（AEC）。我们的总体 目标是改善尼日利亚的癌症控制，并与以下方面合作，对公共卫生产生持续影响： 关键利益攸关方。我们提议的U 54中心汇集了一个跨学科的研究团队， 与主要利益攸关方合作，包括个人、社区以及地方和州卫生部。 U 54计划将促进尼日利亚实施科学（IS）计划，以优化实施 为尼日利亚的癌症控制工作提供疫苗。原子能委员会将负责整体行政工作， 中心的协调和管理以及与NIH的沟通。它将促进合作 研究人员和主要利益攸关方之间的合作，并为公平执行 循证疫苗（即宫颈癌和B型肝炎（HepB）的人乳头瘤病毒疫苗） 肝癌疫苗）用于癌症控制。我们还将制定国家和全球标准， 参与式信息系统研究是在资源有限的环境中进行的， 在尼日利亚有效的癌症控制干预措施的适应性和可持续性。我们的具体目标是：1） 使用敏捷方法协调中心范围内活动的项目管理; 2）作为一个社区 使用众包方法在尼日利亚建立信息系统参与中心;以及3）评估中心的里程碑， 整体进展。通过提供一个基础设施，促进中心范围的通信，业务， 社区外展和评估，AEC将作为一个中心联络点，以加强整体愿景， 降低癌症的发病率和死亡率，同时促进信息系统在公平控制癌症方面的作用， 尼日利亚。